Utama › Penyakit Hati Steatotik › Arizona › Chandler
Kajian klinikal Penyakit Hati Steatotik di Chandler, AZ
10 kajian untuk Penyakit Hati Steatotik sedang mencari peserta di lokasi dalam dan sekitar Chandler (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Mengambil pesertaFasa 3
- 89bio Clinical Study Site, Chandler
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Mengambil pesertaFasa 3
- 89bio Clinical Study Site, Chandler
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Mengambil pesertaFasa 2
- Arizona Liver Health, Chandler
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Mengambil pesertaFasa 3
- The Institute for Liver Health II dba Arizona Clinical Trials - Chandler, Chandler
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Mengambil pesertaFasa 3
- Akero Clinical Study Site, Chandler
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Mengambil pesertaFasa 2
- Arizona Liver Health, Chandler
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Mengambil pesertaFasa 2
- GSK Investigational Site, Chandler
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Mengambil pesertaFasa 3
- GSK Investigational Site, Chandler
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Mengambil pesertaFasa 2
- GSK Investigational Site, Chandler
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
Mengambil peserta
- Arizona Liver Health, Chandler
Kajian Penyakit Hati Steatotik di bandar lain
- San Antonio, TX17 kajian
- New York City, NY16 kajian
- Miami, FL16 kajian
- San Diego, CA14 kajian
- Austin, TX13 kajian
- Houston, TX13 kajian
- Richmond, VA12 kajian
- Tucson, AZ10 kajian
- Hialeah, FL9 kajian
- Dallas, TX9 kajian
- Orlando, FL9 kajian
- St. Louis, MO9 kajian
Kajian lain di Chandler
- Kanser Payudara5 kajian
- Kanser Paru-paru Bukan Sel Kecil5 kajian
- Kanser Kolorektal5 kajian
- Obesiti5 kajian
- Penyakit Pencernaan5 kajian
- Penyakit Hati4 kajian
- Berat Badan Berlebihan4 kajian
- Diabetes Jenis 24 kajian
- Kanser Metastatik4 kajian
- Penyakit Alzheimer3 kajian
- Penyakit Kardiovaskular3 kajian
- Kanser Kolon3 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.